Mitsui Chemicals (4183) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
16 Feb, 2026Executive summary
Operating income before special items for April–December 2025 was JPY 68.0 billion, down 10% year-on-year, mainly due to inventory valuation losses, maintenance, and low operating rates in Basic & Green Materials.
Net income attributable to owners of the parent for the same period was JPY 22.6 billion, down 40% year-on-year, impacted by non-recurring restructuring losses.
Full-year operating income before special items is forecast at JPY 103.0 billion, revised downward due to Basic & Green Materials weakness; net income forecast is JPY 42.0 billion.
Shareholder returns include a JPY 30.0 billion share repurchase and a two-for-one stock split effective January 2026.
Financial highlights
Sales revenue for April–December 2025 was JPY 1,218.7 billion, down 9% year-on-year.
Operating income before special items decreased by 10% year-on-year to JPY 68.0 billion.
Net income for the period was JPY 22.6 billion, down 40% year-on-year.
Non-recurring items totaled -JPY 13.4 billion, mainly from impairment losses and restructuring.
Free cash flow for April–December 2025 was JPY 44.0 billion; cash flows from operating activities were JPY 141.0 billion.
Outlook and guidance
Full-year sales revenue is projected at JPY 1,675.0 billion, down from previous guidance.
Operating income before special items is forecast at JPY 103.0 billion, down from prior outlook.
Net income is forecast at JPY 42.0 billion, below previous forecast.
Dividend outlook remains at JPY 75 per share after the stock split.
Latest events from Mitsui Chemicals
- Operating income before special items jumped 88% YoY in 1Q FY2026, led by specialty chemicals and restructuring.4183
Q1 2027 - Specialty chemicals lead profit growth as global expansion and sustainability accelerate.4183
Investor presentation - FY 2026 profit is set to rise on specialty chemicals growth and restructuring, despite external risks.4183
Q4 2026 - Specialty chemicals strength offsets profit decline; FY2025 outlook and stock split announced.4183
Q2 2026 - Profits fell on restructuring and impairment losses, but specialty chemicals remained resilient.4183
Q1 2026 - Strong YoY growth with positive outlook, but Osaka plant outage adds uncertainty.4183
Q1 2025 - H1 FY2024 profit surged 26% YoY; full-year growth expected despite plant and input cost issues.4183
Q2 2025 - FY2025 profit rebound is forecast despite net income drop and trade policy risks.4183
Q4 2025 - Profits rose on Specialty Chemicals and Mobility Solutions, offsetting Basic & Green Materials losses.4183
Q3 2025